CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	3 Months Ended
Mar. 31, 2020	Mar. 31, 2019
Cash flows from operating activities:
Net income	$ 8,326	$ 16,037
Adjustments to reconcile net income to net cash provided by operating activities:
Provision for credit losses	9,329	1,283
Depreciation and amortization of premises and equipment	1,504	1,540
Non-cash lease expense	59	79
Cash flows from operating leases	(1,594)	(1,549)
Loss on sale of other real estate, net of write-downs	64	138
Amortization of mortgage servicing rights	1,547	471
Net amortization and accretion of premium/discounts on investment securities	1,982	2,211
Share-based compensation expense	673	498
Net gain on sales of residential mortgage loans	(727)	(611)
Proceeds from sales of loans held for sale	31,498	31,877
Originations of loans held for sale	(25,598)	(28,158)
Equity in earnings of unconsolidated subsidiaries	(26)	(8)
Distributions from unconsolidated subsidiaries	73	82
Net decrease (increase) in cash surrender value of bank-owned life insurance	19	(952)
Deferred income taxes	(406)	5,013
Net tax benefits from share-based compensation	(48)	105
Net change in other assets and liabilities	4,570	(2,173)
Net cash provided by operating activities	31,245	25,883
Cash flows from investing activities:
Proceeds from maturities of and calls on investment securities available-for-sale	50,878	43,093
Purchases of investment securities available-for-sale	(96,068)	0
Proceeds from sale of MasterCard stock	0	2,555
Net loan originations	(41,339)	(6,851)
Purchases of loan portfolios	(22,340)	(18,286)
Net purchases of premises, equipment and land	(5,608)	(782)
Net return of capital from unconsolidated subsidiaries	0	622
Contributions to unconsolidated subsidiaries	(422)	0
Net (purchases of) proceeds from redemption of FHLB stock	(3,126)	500
Net cash (used in) / provided by investing activities	(118,025)	20,851
Cash flows from financing activities:
Net increase in deposits	16,046	1,638
Repayments of long-term debt	0	(20,619)
Net increase (decrease) in short-term borrowings	72,000	(18,000)
Cash dividends paid on common stock	(6,496)	(6,052)
Repurchases of common stock and other related costs	(4,749)	(7,708)
Net cash provided by financing activities	76,801	(50,741)
Net decrease in cash and cash equivalents	(9,979)	(4,007)
Cash and cash equivalents at beginning of period	102,972	102,186
Cash and cash equivalents at end of period	92,993	98,179
Cash paid during the period for
Interest	6,140	8,402
Income taxes	170	0
Net transfer of investment securities held-to-maturity to available-for-sale	0	(149,042)
Right-of-use lease assets obtained in exchange for lease liabilities	$ 0	$ 55,887

The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets, and the amount of impairment loss recognized in the period resulting from the write-down of the carrying amount of a finite-lived intangible asset to fair value.

No definition available.